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Abstract
Background: Acute reduction in hemoglobin levels is frequently seen during sepsis. Previous studies have focused
on the management of anemia in patients with septic shock admitted to intensive care units (ICU’s), including
aggressive blood transfusion aiming to enhance tissue oxygenation.
Aim: To study the changes in hemoglobin concentrations during the first week of sepsis in the setting of Internal
Medicine (IM) units, and their correlation to survival.
Design: Observational prospective study.
Methods: We recorded hemoglobin values upon admission and throughout the first week of hospital stay in a
consecutive cohort of septic patients admitted to IM units at a community hospital, the patients were enrolled into
a prospective registry.
Data on blood transfusions was also collected, we examined the correlation between hemoglobin concentrations
during the first week of sepsis and survival, the effect of blood transfusion was also assessed.
Results: Eight hundred and fifteen patients (815) with sepsis were enrolled between February 2008 to January
2009. More than 20 % of them had hemoglobin levels less than 10g/dL on admission, a rate that was doubled
during the first week of sepsis. Overall, 68 (8.3 %) received blood transfusions, 14 of them (20.6 %) due to bleeding.
Typically, blood transfusion was given to older patients with a higher rate of malignancy and lower hemoglobin
levels. While hemoglobin concentration on admission had strong correlation with in-hospital mortality (O.R-0.83
[95 % C.I. 0.74–0.92], blood transfusion was not found to be an independent predicting factor for mortality.
Conclusion: Anemia is very common in sepsis. While hemoglobin level on admission exhibit independent
correlation with survival, blood transfusion do not.
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Background
Anemia is a common problem encountered in patients
with sepsis. Several mechanisms contribute to acute
reduction in hemoglobin levels in the setting of sepsis, in-
cluding reduced production of red blood cells induced by
the systemic inflammatory response, as well as increased
destruction of red cells due to hemolysis and bleeding.
The combination of anemia and alterations in oxygen
consumption induced by sepsis may augment impairment
of tissue oxygenation. Treatment of septic patients also
aims at optimizing the delivery of oxygen to tissues in
order to alleviate cellular hypoxia and the progression of
cell dysfunction, in an attempt to avoid or attenuate the
development of multiple organ dysfunction syndrome [1].
Based on this notion, maintenance of adequate blood
hemoglobin level was suggested as one of the tools to
diminish sepsis induced tissue damage. The concept of
maintaining a minimal hematocrit level in the acute treat-
ment of sepsis was emphasized in the early goal-directed
therapy (EGDT) trial, by targeting a hematocrit value of
30 % in patients with low ScvO2 (Central venous oxygen
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saturation) during the first 6 h of the resuscitation of sep-
tic shock [2].
Of note, recent trials found no benefit for protocol-
based resuscitation in the context of septic shock [3–5].
According to the Surviving Sepsis Campaign guidelines
updated in 2012, septic patients with hemoglobin concen-
tration of <7g/dL should receive RBC transfusion in order
to achieve hemoglobin target values of 7–9gr/dL [6].
This recommendation is based on the Transfusion Re-
quirements in Critical Care trial [7], in which less than
5 % of the enrolled patients were with primary diagnosis
of sepsis, while the majority endured respiratory or
cardiovascular diseases or trauma. Furthermore, the study
population was significantly younger with a mean age of
57.6 years [7], while more commonly the mean age of sep-
tic patients is significantly older [8, 9], and the majority of
septic patients in previous studies were treated in general
departments rather than in ICUs [8, 10]. Furthermore, in
recent studies targeting the issue of optimal hemoglobin
level in sepsis, the focus was on patients with septic shock
that were treated in ICU settings.
Worldwide, steadily increasing numbers of elderly
patients with sepsis are treated in general departments
including Internal Medicine units by internist doctors.
Only few studies focus directly on this group of patients.
In the present study, we characterized acute changes in
hemoglobin levels during the first week of sepsis in
patients admitted to IM (Internal Medicine) departments
and its correlation to in-hospital mortality and overall sur-
vival. In order to evaluate the practice of blood transfusion
in this setting, we also compared the characteristics and
outcome of patients who received blood transfusions as
part of their treatment to those who did not.
Methods
Our study is based on a registry of septic patients admitted
to IM departments during one- year period in a 450-bed
community-based university hospital in Haifa, Israel.
The data were collected prospectively for patients
fulfilling sepsis criteria on their admission according to
the American College of Chest Physicians/Society of
Critical Care (ACCP/SCCM) Consensus Conference in
1991 [11], i.e. patients who were admitted with
suspected infection and at least two of the criteria for
SIRS. No exclusion criteria were employed.
The patients were categorized with sepsis based on the
above- mentioned criteria determined by the treating
physicians. The definitions were stated in the electronic
questionnaire where the admitting physician marked the
appropriate category of sepsis for the patient upon
admission only. The diagnosis was not revised any more
later on the hospital stay or during the discharge. During
the study period, the hospital had no specific constructed
protocol for the diagnosis and treatment of sepsis. Yet,
generally the septic patients treatment was affected largely
by the concept of starting antibiotics and fluids as soon as
possible once the patient was diagnosed with sepsis.
The data that were recorded included information
related to current illness such as vital signs, e.g. heart rate,
respiratory rate, body temperature, systolic and diastolic
blood pressure, and oxygen saturation. Physicians were
instructed to register the worst value of each of the
variables until admission to the department, including
Emergency Department values. Demographic data that
were collected included gender, age, functional status and
mental status. Data on co-morbidities included ischemic
heart disease, congestive heart failure, chronic obstructive
pulmonary disease, hypertension, diabetes mellitus,
chronic kidney disease, liver disease and cancer. Clinical
status at presentation was ascertained using ACCP/SCCM
sepsis definition (sepsis, severe sepsis, septic shock) [11].
Laboratory results were drawn automatically and
included hemoglobin concentrations on admission, the
minimal values during the first 7 days of sepsis and
values at the end of the first week. We also collected
data on blood transfusions during hospitalization.
Major outcomes were collected including mortality (in-
hospital and after discharge) up to 2 years of follow up.
The study was approved by the hospital local ethics
committee: Carmel medical center ethics committee.
No informed consents were needed from the patients.
Statistical methods
Baseline characteristics were compared with the ANOVA
(F-Test) and t-test for continuous variables (3 or 2 cat-
egories, respectively), and Wilcoxon’s scores or chi square
test for parametric or discrete variables, respectively.
Univariate comparison of survival between two or more
groups with the LIFETEST procedure, which computes
nonparametric estimates of the survival distribution func-
tion. We used the product-limit (Kaplan and Meier).
PROC LIFETEST computes nonparametric tests to
compare the survival curves of two or more groups. The
procedure also computed rank tests of association of the
survival time variable with other concomitant variables.
Survival models (explaining survival by multiple
continuous and discrete variables), used the partial likeli-
hood of the Cox model as the likelihood and generated a
chain of posterior distribution samples by the Gibbs
Sampler. Summary statistics, convergence diagnostics, and
diagnostic plots were provided for each parameter. A back-
ward stepwise elimination method using Wald Chi-Square
was used to achieve a model with only significant factors.
Logistic regression was used to explain two level
parameters such as hospital mortality. The computations
were done by SAS9.2 Software procedures GLM, FREQ,
NONPAR1WAY, LOGISTIC, PHREG, LIFETEST and
more.
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Results
Between February 1, 2008 and January 30, 2009, 815
patients were admitted to the IM departments at our
medical center with a diagnosis compatible with sepsis.
We classified our cohort according to hemoglobin levels
as follows: normal to mildly reduced hemoglobin
concentration (≥10g/dL), moderately reduced concentra-
tion (≥7 and <10g/dL) and severely reduced hemoglobin
concentration (<7g/dL) . The characteristics of the
cohort are detailed in Table 1. As expected in this setting
the study population was old with a high proportion of
patients with cognitive and functional status decline and
co-morbidities. Most patients (77 %) had hemoglobin
concentrations of ≥ 10g/dL on admission, while less than
1 % had severely reduced levels. The average values of
mean corpuscular volume (MCV) and mean corpuscular
hemoglobin (MCH) on admission for the entire cohort
were 85.7 ± 6.6 (normal range 80–96 fl) and 28.68 ± 4.38
(normal range 27.5–33.2 pg), respectively and did not
differ significantly between the three groups classified by
hemoglobin concentration on admission. As shown it
Table 1 the groups of patients with moderately and
severely reduced hemoglobin levels on admission had
higher proportions of chronic kidney disease (CKD) and
dialysis and terminal diseases (expected life expectancy
of less than one month) and/or malignancy than the
group of normal to mildly reduced hemoglobin concen-
tration. The latter group also had a significantly higher
systolic blood pressure and lower serum creatinine and
urea. There were no significant differences between the
three groups concerning the rates of severe sepsis and
septic shock on presentation, as well as in respiratory
parameters, need for respiratory support, and acute
cardiovascular events (Table 1).
Hemoglobin changes during the first week of
hospitalization are shown in Fig. 1. On admission, the
mean hemoglobin value of the whole study group was
11.5 ± 2.0g/dl. The maximal reduction in hemoglobin
was seen within a mean time of 2.1 ± 1.9 days, with a
mean decrease of 1.08 ± 1.04 g/dL. The absolute reduc-
tion was higher in patients with normal to mildly
reduced hemoglobin concentration on admission com-
pared to patients with moderately and severely reduced
levels (1.2 ± 1.0, 0.5 ± 0.6 and 0.14 ± 0.25, respectively)
and occurred later (2.3 ± 1.9 vs. 1.5 ± 1.8 and 0.7 ± 1.4
days, P < 0.001).
Lowest hemoglobin values throughout the first week
were moderately reduced in 315 patients (38.7 %) and
severely reduced in 18 (2.2 %). At the end of the first
week, moderately and severely reduced levels were
observed in 196 (24 %) and 4 (0.5 %) of the patients,
respectively.
Sixty-eight patients (8.3 %) were transfused with
packed red blood cells, the mean hemoglobin level
which necessitate transfusion was 7.86 ± 1.16 gr/dl; the
nadir hemoglobin levels in this group of patients
occurred within a mean time of 4.4 ± 5.1 days from
admission. Bleeding occurred in 22 patients, mostly
gastrointestinal bleeding (63 %). Retroperitoneal, cranial,
muco-cutaneous and genitourinary bleeding constituted
the remaining events (37 %).
During the study, there was no specific transfusion
protocol. Ordering blood transfusion is an independent
decision of the treating physician based usually on
clinical consideration rather the absolute levels of
Hemoglobin.
Transfusion reactions occurred in two cases, and both
were nonfatal hemolytic reactions. Table 2 shows
comparison between patients who received blood trans-
fusions to those who did not. Patients who received
transfusions were older, with higher proportion of
dementia, malignancy and terminal diseases. There were
no significant differences in the rates of acute cardiovas-
cular events or respiratory failure among patients who
received transfusion and those who did not.
Thirty-four percent of the study cohort survived
throughout a mean follow-up of 675.1 ± 634.8 days. The
survival rate differed significantly according to
hemoglobin concentration on admission as follows;
38.5 % in patients with normal to mildly reduced level,
18.6 % for moderately reduced level, and 14.2 % for
severely reduced level (p < 0.0001), respectively. Kaplan-
Meier curves of survival according to hemoglobin
concentration on admission are given in Fig. 2. The
same trend of survival is seen in comparisons that were
based on the lowest value of hemoglobin during, and at
the end of the first hospitalization week.
The in-hospital mortality rate was 22.8 % for the entire
cohort with significantly increasing rates as hemoglobin
admission level decreased.
The significant factors found to correlate with in-hos-
pital mortality are summarized in Table 3. In adittion to
other parameters, higher hemoglobin on admission was
found to have a protective effect, OR = 0.83 (P = 0.0004).
Although a higher rate of in-hospital mortality (36.7 %
vs. 21.5 % p < 0.05) and a lower survival rate (17.6 % vs.
35.4 % p < 0.05) were seen in patients who received
blood transfusions, this parameter was not found to be
an independent significant factor in multivariate regres-
sion and survival model analyses.
Discussion
The present study shows that patients with sepsis admit-
ted to IM departments frequently have anemia at an
early stage of sepsis, which worsens during the first few
days after admission to the hospital. The mean
hemoglobin concentration on admission in our cohort
was 11.5 ± 2.0. A hemoglobin concentration of less than
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10g/dL was observed in more than 20 % of the present
study patients already on presentation. This rate
increased to almost 40 % during the first few days of
hospital stay, and still observed in one fourth of our
septic patients at the end of first week. In the absence of
information on baseline hemoglobin values before
admission, the low levels on presentation may either be
an expression of chronic anemia in patients with a high
Table 1 Characteristics of patients according to hemoglobin levels on admission, classified into three groups: HGB ≥ 10, HGB≥ 7- <
10, HGB < 7 g/dL
Parameter HGB≥ 10 HGB≥ 7- < 10 HGB < 7 P value
no. of patients 631 (77 %) 177(22 %) 7(1 %)
Age (Mean ± S.D.) 74.3 ± 16.2 77.3 ± 13.5 72.5 ± 15.1 0.07
Females (%) 308 (48.8 %) 83(46.8 %) 5(71.4 %) 0.97
Residence
Home 502(79.6) 138(78.0) 5(71.4)
Nursing home/LTCF 129(20.4) 39 (22) 2(28.6) 0.50
Mental status at baseline
Dementia 208 (36.1) 70(43.7) 2(28.5) 0.18
Normal 363 (63) 88 (55)
Other 5 (0.8) 2 (1.2) 5 (71.4)0 (0)
Basic functional status
Debilitated 250(40.1) 80(45.9) 3(42.8) 0.06
Partially debilitated 62(9.9) 22(12.6) 2(28.5)
Normal 310(49.8) 72(41.3) 2(28.5)
CHF 211(33.4) 68(38.4) 2(28.5) 0.30
IHD 255(40.4) 76(42.9) 1(14.2) 0.97
Diabetes mellitus 217(34.3) 70(39.5) 1(14.2) 0.45
CKD 158(25.0) 69(38.9) 2(28.5) 0.0007
Chronic dialysis 11(1.7) 10(5.6) 0(0) 0.011
Active cancer 97(15.3) 71(40.1) 2(28.5) <.0001
Terminal disease 42(6.6) 37(20.9) 2(28.5) <.0001
Sepsis stage on admission
Severe sepsis 57(9.0) 17(9.6) 0(0)
Septic shock 28(4.4) 13(7.3) 2(28.5) 0.18
Source of infection
Pneumonia 263(41.6) 54(30.5) 2 (28.5)
UTI 183(29.0) 51(28.8) 1(14.2) 0.87
SSTI 34(5.3) 18(10.1) 1(14.9)
Intra-abdominal 6(3.3) 6(3.3) 0(0)
Other 37(5.8) 18(10.1) 1(14.2)
Unknown 105(16.6) 30(16.9) 2(28.5)
Acute myocardial infarction 23(3.65) 7(3.9) 1(14.3) 0.34
Acute respiratory failure 9(1.4) 1(0.5) 0(0) 0.33
CHF exacerbation 25(3.9) 6(3.3) 0(0) 0.60
Systolic BP 121.9 ± 26.8 115.8 ± 27.7 111.2 ± 22.1 0.02
Glasgow coma scale 12.4 ± 3.9 12.1 ± 3.9 11.1 ± 5.1 0.49
Serum Creatinine 1.2 ± 0.9 1.6 ± 1.3 1.5 ± 1.1 0.0002
Serum urea 65.3 ± 46.3 82.8 ± 51.1 80.0 ± 51.4 <.0001
HGB hemoglobin, CHF congestive heart failure, IHD ischemic heart disease, CKD chronic kidney disease, UTI urinary tract infection, SSTI skin and soft tissue
infection, BP blood pressure
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rate of co-morbidities or an acute reduction due to sep-
sis, as well as a combination of both etiologies. Anemia
in sepsis is observed frequently [12, 13] and has a multi-
factorial etiology, including a decrease in production of
erythropoietin due to inflammatory cytokines release,
such as tumor necrosis factor (TNF-α), interleukin-1
(IL-1), and interleukin-6 (IL-6). Interferon gamma and
IL-1 also seem to act directly by inhibiting the growth of
pro-erythrogenic cells and apoptosis of erythroid precur-
sors, thus contributing to the development of anemia in
Fig. 1 Hemoglobin level changes during first week classified according to admission level
Table 2 Characteristics of patients who received blood transfusions and those who did not
Parameter Transfused Not transfused P value
no. of patients 68 747
Age (Mean ± S.D.) 78.8 ± 11.0 74.6 ± 16.0 0.03
Female n (%) 36(52.9) 360(48.1) 0.45
CHF 21(30.8) 260(34.8) 0.51
IHD 24(35.2) 308(41.2) 0.34
Diabetes mellitus 28(41.1) 260(34.8) 0.29
CKD 24(35.2) 205(27.4) 0.16
Chronic dialysis 2(2.9) 19(2.5) 0.84
Active cancer 23(33.8) 147(19.6) 0.006
Terminal disease 13(19.1) 68(9.1) 0.0083
Sepsis stage on admission
Severe sepsis 6(8.8) 68(9.1) 0.66
Septic shock 6(8.8) 37(4.9)
acute myocardial infarction 2(2.9) 29(3.9) 0.69
Acute respiratory failure 1(1.4) 9(1.2) 0.84
CHF exacerbation 4(5.8) 27(3.6) 0.34
HGB on admission 9.25 ± 1.91 11.73 ± 1.92 <0.0001
Minimal HGB 7.86 ± 1.16 10.68 ± 1.77 <0.0001
HGB on day 7 9.72 ± 1.36 11.38 ± 1.79 <.0001
Time from admission to minimal HGB (days) 2.30 ± 1.36 2.18 ± 1.79 0.9821
ΔHGB (admission-minimal HGB); 1.39 ± 1.44 1.06 ± 0.99 0.0127
HGB hemoglobin, LTCF long term care fascility, CHF congestive heart failure, IHD ischemic heart disease, CKD chronic kidney
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these patients [14]. Other mechanisms that may contrib-
ute to hemoglobin reduction in sepsis are stress-induced
gastrointestinal bleeding/hemodilution due to fluid over-
load, recurrent blood withdrawal for laboratory analysis,
impaired iron metabolism, hemolysis as part of the
pathogenesis of some infectious processes, bleeding due
to DIC, and possibly increased red cell destruction due
to alterations in red blood cells membranes [14].
As mentioned previously, another possible explanation
for low hemoglobin levels on presentation in our cohort
maybe due to anemia of chronic diseases. The study
population had a high rate of co-morbidities, including
malignancy and CKD that were documented in more than
half of the cases. CKD and active cancer are well known
causes of anemia due to several mechanisms [15, 16]. On
the other hand, the worsening in hemoglobin levels in our
study subjects during the first week of hospital stay
presented in an average reduction of 1.09 ± 1.04 g/dL with
minimal concentrations occurring within 2.19 ± 1.99 days
from presentation reflects development of anemia as an
important part of the course of sepsis..
The fact that the absolute reduction was higher in
patients with higher hemoglobin concentrations on admis-
sion (normal to mildly reduced vs. moderately reduced vs.
severely reduced levels) and occurred later (Fig. 1) may
reflect their presentation for treatment at an earlier stage of
Fig. 2 Survival probability according to hemoglobin level on admission
Table 3 Odds ratios and Wald confidence intervals for in-hospital mortality
Parameter O.R. 95 % C.I. P value
Age For increase of 1 year 1.020 1.001–1.040 0.0438
Terminal disease Yes vs. no 1.964 1.097–3.517 0.0231
Stand without help No vs. yes 1.869 1.153–3.027 0.0111
Dyspnea on admission No vs. yes 0.339 0.223–0.517 <0.0001
Abnormal ECG on admission No vs. yes 0.553 0.370–0.829 0.0041
Systolic blood pressure on admission For increase of 1 mmHg 0.992 0.985–0.999 0.0290
Glasgow coma scale on admission For increase of 1 point 0.902 0.858–0.947 <.0001
Hemoglobin on admission For increase of 1 gr/dl 0.830 0.748–0.921 0.0004
Serum urea on admission For increase of 1 mg/dl 1.010 1.006–1.014 <.0001
O.R odds ratio, CI confidence interval, ECG electrocardiograph, BP blood pressure
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sepsis and could explain its correlation with better survival
(Fig. 2). In logistic regression analysis, hemoglobin levels on
admission, had a correlation with in hospital mortality (OR.
0.83, p = 0.0004) the higher the hemoglobin level the better
was the prognosis. The negative correlation between low
hemoglobin concentration and survival in sepsis had been
observed in previous studies [12, 13].
The fact that the present study is an observational
one, supplies mainly description of the correlation be-
tween generally poor health, anemia, and poor outcomes
in sepsis, rather than a direct causative correlation
between low hemoglobin and mortality in sepsis.
Although it is known that lower hemoglobin concen-
tration in the context of increased oxygen demand as is
frequently the case in sepsis may play a negative role
and augment organ dysfunction, forced elevation of
hemoglobin concentration by blood transfusions does
not necessarily mean improvement in organ function
[17]. Hence, the role of blood transfusion in preservation
of organ function in sepsis is still debated. In order to
characterize blood transfusion practice in our cohort, we
compared the characteristics of patients who received
blood transfusions to those who did not. 8 % of the
cohort received blood transfusions. These patients were
significantly older by an average of 4 years with higher
rates of malignancies and terminal diseases (Table 2).
Bleeding was documented in 20 % of the transfused
patients, while in the remaining cases it seems that
hemoglobin concentration was the indication for trans-
fusion, with a significantly higher percent of patients
with moderately and severely reduced hemoglobin levels
on admission. Although older, patients that received
blood transfusions had no significant differences in the
rate of acute events of myocardial infarction or respira-
tory failure as may be expected; neither had they had
more co-morbid cardiovascular diseases. A similar find-
ing regarding the lower hemoglobin level as the main
difference between transfused and non-transfused
patients was shown in a previous study that investigated
blood transfusion in patients with septic shock treated in
an ICU [18]. An important consideration related to
blood transfusion is the complications that are described
in about 20 % of cases [19]. In our cohort, the rate of
complications was low (about 3 %) mostly non fatal
hemolytic reactions. As was mentioned before, the deci-
sion of giving a blood transfusion for any patient in our
hospital is based on the treating physician consideration
rather than a specific transfusion protocol.
In our cohort, although transfused patients had a
significantly higher in hospital mortality and worse long-
time survival, blood transfusion itself was not found to
be an independent risk factor for these outcomes, but it
rather seems to be a marker of a disease severity as the
transfused patients were older, more debilitated and
endured terminal diseases more frequently. Previous stud-
ies investigating the correlation between blood transfusion
in sepsis and mortality found conflicting results. While as
observed in the present study, in some studies blood
transfusion was not found to correlate with mortality
[18, 20–22] other studies showed an improved outcome
for patients who received blood transfusion [23, 24]. It
is important to emphasize that these studies focused
mainly on critically ill patients with septic shock in the
setting of ICU, while our cohort included patients with
a wide range of disease severity of sepsis and older pa-
tients with high proportion of chronic diseases, repre-
senting the majority of patients with sepsis at hospitals.
Whether or not increasing hemoglobin level can
improve the prognosis in sepsis is still an unresolved
question as is the controversial issue of hemoglobin
concentration threshold for transfusion and the desired
optimal level that should be targeted. A significant pro-
gression in this field had been achieved in cases of septic
shock, mainly due to a recent large, multicenter,
randomized study that compared a hemoglobin level
threshold of 9 g/dL vs. 7 g/dL for blood transfusion in
patients with septic shock in the ICU and found no
difference in 90 day mortality [25].
Learning points
 Our study investigated an important population of
patients with sepsis that is treated in general
departments that differs significantly from those
treated at ICUs and seems to represents better the
majority of patients with sepsis in hospitals.
 Our study shows the beneficial effect of higher
hemoglobin levels on presentation and during early
stage of sepsis, yet due to the observational design of
the current study the results do not support
conclusions about optimal hemoglobin
concentration and the optimal strategy for blood
transfusions in septic patients in the setting of IM
departments.
Conclusions
Our study shows the beneficial effect of higher
hemoglobin levels on presentation and during early stage
of sepsis. Currently, most physicians adopt a “restrictive”
strategy of blood transfusion (transfuse when hemoglobin
level < 7 g/dL) as recommended, except in acute
hemorrhage or in patients with acute myocardial ischemia
where a more liberal strategy is the usual practice [26].
Still, our study is a descriptive one that demonstrates
an association between low hemoglobin levels and
worsened outcome. Whether an interventional approach
targeting higher hemoglobin levels can improve the
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outcome of patients with sepsis remains to be deter-
mined in future prospective studies.
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